- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
New Advances and Approaches in Thyroid Cancer
Deadline: 31 August 2026
Advances in the Early Diagnosis and Treatment of Gastric Cancer (2nd Edition)
Deadline: 31 August 2026
Advances in the Multimodal Management of Pancreatic Ductal Adenocarcinoma
Deadline: 31 August 2026
Modern Approach to Oral Cancer
Deadline: 30 August 2026
Robotic and Laparoscopic Surgery in Colorectal Cancer: Current Trends and Future Perspectives
Deadline: 30 August 2026
Research on Fluorescence-Guided Surgery in Cancer Treatment (2nd Edition)
Deadline: 30 August 2026
Contemporary Advances and Challenges in Multimodal Management of Gastric Cancer
Deadline: 25 August 2026
Contemporary Diagnosis and Management of Prostate Cancer (2nd Edition)
Deadline: 22 August 2026
Rare Cancers, Diagnostic Challenges and Personalized Therapeutic Approaches in the 21st Century (2nd Edition)
Deadline: 20 August 2026
Cytoreduction in Gynecologic Oncology
Deadline: 14 August 2026
Clinical Surgery for Hepato-Pancreato-Biliary (HPB) Cancer
Deadline: 10 August 2026
Novel Therapies in Metastatic Castration-Resistant Prostate Cancer
Deadline: 1 August 2026
of 68

